Coronavirus Impact On Haryana

Ministry of Ayush has launched a special edition of the official research publication of the Central Council for Research in Ayurvedic Sciences (CCRAS), Journal of Research in Ayurvedic Sciences (JRAS) focused on the “Impact of Mann ki Baat on Ayush Sector”. Minister of Ayush and Ports, Shipping & Waterways Shri Sarbananda Sonowal today launched the special edition of the journal in the presence of Vaidya Rajesh Kotecha, Secretary, of Ayush, and senior officials of the Ministry. In his address, Shri Sarbananda Sonowal said,  “Prime Minister’s “Mann ki Baat” conversations have been instrumental in giving a positive trust to Ayush. With its innovative and unique interactive style of presentation, the radio program has carved out a niche for itself and has become popular among communities. The content of this special edition of the journal has taken inspiration from various thoughts of our PM on the Ayush sector.” Ayush has been mentioned in about 37 of the “Mann Ki Baat” episodes. The Prime Minister had urged citizens to adopt a healthy lifestyle, practice yoga, and adopt evidence-based Ayurveda and imbibe the Ayurveda way of life into their lifestyle. As a result of the Prime Minister’s efforts to promote the Ayush sector, there has been an increase in awareness about the benefits of traditional Indian systems of medicine, not only in India but also globally. The content of the special edition of the journal is inspired by various conversations of Hon’ble Prime Minister Shri Narendra Modi on Ayush systems during the last 9 years. It highlights the impact of “Mann ki Baat” on the Ayush sector and how Ayush is becoming a fundamental pillar of the country’s national health policy and health interventions.  A total of 24 articles by renowned experts are included in 7 potential areas i.e. Policy & Public Health, Science & Evidence, Health Education & Awareness, Yoga & Swasthavritta (Lifestyle, Exercise, Food, Nutrition), War against Corona, Industry & Academia Collaboration and Globalization & International Cooperation. The special edition includes a special message from Minister of Ayush Shri Sarbananda Sonowal, Minister of State for Ayush Dr. Munjapara Mahendrabhai. Vaidya Rajesh Kotecha, secretary, Ministry of Ayush, eminent authors from academia (like Dr. BN Gangadhar, NMC and former Director NIMHANS), Industry (Like Acharya Balkrishna of Patanjali, Dr. C K Katiyar of Emami), Research (Dr. Viswajanani Sattigeri of CSIR-TKDL), Clinicians, experts (Dr. Rajendra A Badwe, Director, Tata Memorial Centre, Mumbai), Biotechnology experts (Kalpana Joshi, Professor, and Head Biotechnology, Savitribhai Phule Pune University), International experts and stakeholders (from Germany, Sweden, and USA) have contributed in this edition. Journal of Research in Ayurvedic Sciences (JRAS) is a peer-reviewed, open access, UGC-CARE-listed official publication of the Central Council for Research in Ayurvedic Sciences (CCRAS), New Delhi. The Journal is published quarterly and is available in both print and online forms. It is a multidisciplinary platform for the publication of research in Ayurveda, Yoga, Naturopathy, Siddha, and Homeopathy fields including interdisciplinary health sciences. The journal is published by Medknow, which is a part of Wolters Kluwer Health, one of the largest open-access publishers worldwide with more than 450+ medical journals in its portfolio. Also, Read This in Hindi► मन की बात संवाद आयुष को सकारात्मक विश्वास प्रदान करने में मददगार - सर्बानंद सोनोवाल

A brain tumour develops when certain genes in a cell's chromosomes become faulty and cease to function properly. These genes typically regulate the rate at which the cell divides and repair genes that correct deficiencies in other genes, as well as genes that should cause the cell to self-destruct if the damage is irreparable. A person may be born with a partial defect in one or more of these genes. Environmental factors may then cause additional mutilation. In a few other cases, however, environmental damage to the genes can be viewed as the sole factor. Behavioural Changes That Brain Tumours Cause Brain tumours and their treatments, in general, can alter a person's behaviour and ability to think. Patients' communication, concentration, and memory skills may suffer, and their personalities may shift. Brain tumours frequently cause personality changes and mood swings. Although the severity of these mood changes varies from person to person, it is relatively common for someone with a brain tumour to experience increased aggression and agitation. A brain tumour may also cause weakness, dizzy spells, poor balance or lack of coordination, personality or behaviour changes, confusion, speech problems, and fits (seizures). However, it is critical to note that the impact of a brain tumour on quality of life is determined by whether the tumour is benign or malignant in nature. Benign Tumour In the case of benign tumours, there is little variation in the patient's quality of life. There may be neurological deficits that can be corrected with regular physiotherapy and rehabilitation. We can keep a close eye on tumour recurrence using serial imaging. In the event of a relapse, the patient may be subjected to radiation or surgery. To answer an underlying question, a benign tumour does not impair quality of life after the ailment has been contracted. Most tumours do not leave residual deficits, making it simple to return to normalcy with timely rehabilitation and psychotherapy. Malignant Tumour The outcome of a malignant brain tumour is determined by the grade of the tumour itself. If the tumour is of Grade 1, the characteristic features that accompany it behave more or less like a benign tumour. However, chemotherapy and radiation are required for a Grade 4 tumour, which causes skin discoloration, hair loss, fatigue, and other physiological changes. As a result, people's quality of life suffers. Nonetheless, with the proper treatment and time, these changes are completely reversible. One thing to remember, regardless of the nature of the tumour, is to maintain a positive attitude toward the illness itself. A strong mind-set greatly aids the patient in overcoming the trauma of having a cancerous brain tumour. A holistic, positive outlook on life can go a long way toward rehabilitating a post-ailment patient. Needless to say, family support and strength go a long way toward a fruitful and blissful life for the patient. (Dr. Ravi Gopal Varma, Lead Consultant Neurosurgery & Program Director - Global Centre of Excellence in Neurosciences, Aster Hospitals Bangalore) Read More► Signs to Detect Vitiligo

Six in 10 people with SARS-CoV-2 still have at least one symptom of long Covid a year later, with fatigue, shortness of breath and irritability being the most common, a new study has shown. The study, being presented at this year's European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) in Portugal, found that Covid-19 symptoms that don't clear up after 15 weeks are likely to last at least a year. An estimated 25-40 per cent of people with Covid-19 develop long Covid, persisting symptoms that can affect multiple organs and include mental health problems. Most of the data to date, however, is based on patients who were hospitalised with Covid-19 and it isn't clear how it applies to Covid-19 cases more generally. To find out more, Aurelie Fischer and colleagues at the Luxembourg Institute of Health in Luxembourg, surveyed almost 300 people a year after they were diagnosed with Covid. The 289 participants (50.2 per cent women) had an average age of 40.2 years and were divided in three groups, based on the severity of their initial infection: asymptomatic, mild and moderate/severe Covid-19. They were asked to fill in a detailed questionnaire about whether they were experiencing 64 common long Covid-related symptoms. A third (34.3 per cent) were experiencing fatigue a year on, 12.9 per cent said respiratory symptoms were affecting their quality of life and more than half (54.2 per cent) had ongoing sleep problems. Participants who had moderate/severe Covid-19 were twice as likely to still have at least one symptom a year on than those whose initial infection was asymptomatic. Having had moderate/severe Covid-19 was also associated with more sleep problems after a year than being asymptomatic (63.8 per cent vs. 38.6 per cent). "Participants with a mild form of the acute illness were more likely than those who'd been asymptomatic to have at least one symptom at one year, and to have sleep problems, but to a lesser extent than those with a moderate or severe acute illness," Fischer said. One in seven participants (14.2 per cent) said they could not envisage coping with their symptoms long-term. Further, the analysis also revealed that some groups of symptoms tend to occur together, suggesting that there are multiple different types of long Covid. Read More► Covid Not Only Infects Human Retina, But Can Also Replicate in It

New York: A team of researchers has provided important insights into how SARS-CoV-2 the virus responsible for Covid-19 can lead to long-term pain. Using a hamster model of SARS-CoV-2 infection, the research team found that the infection left a gene expression signature in the dorsal root ganglia that remained even after the virus cleared. The signature matched gene expression patterns seen in pain caused by other conditions. "A significant number of people suffering from long Covid experience sensory abnormalities, including various forms of pain," said researcher Randal (Alex) Serafini from the Icahn School of Medicine at Mount Sinai in New York City. "We used RNA sequencing to get a snapshot of the biochemical changes SARS-CoV-2 triggers in a pain-transmitting structure called dorsal root ganglia," Serafini added. For the study, to be presented at the American Society for Pharmacology and Experimental Therapeutics' annual meeting, the research team involved a hamster model of intranasal Covid-19 infection that closely reflected the symptoms experienced by people. The researchers observed that SARS-CoV-2-infected hamsters showed a slight hypersensitivity to touch early after infection, which became more severe over time, up to 30 days. They then performed similar experiments with the Influenza A virus to determine if other RNA viruses promote similar responses. In contrast to SARS-CoV-2, Influenza A caused an early hypersensitivity that was more severe but faded by four days post-infection. Analysis of gene expression patterns in the dorsal root ganglia revealed that SARS-CoV-2 caused a more prominent change in expression levels of genes implicated in neuron-specific signalling processes compared to influenza. Additional experiments showed that four weeks after recovering from a viral infection, flu-infected hamsters had no signs of long-term hypersensitivity, while SARS-CoV-2-infected hamsters showed worsened hypersensitivity, reflecting chronic pain. The hamsters that had recovered from SARS-CoV-2 had gene expression signatures similar to those seen in the dorsal root ganglia of mice affected by pain that was induced by inflammation or nerve injury. Read More► Covid Not Only Infects Human Retina, But Can Also Replicate in It